Barclays’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-44
Closed -$2K 5359
2022
Q1
$2K Buy
+44
New +$2.64K ﹤0.01% 4803
2020
Q3
Sell
-20
Closed -$11K 5693
2020
Q2
$11K Buy
+20
New +$11.7K ﹤0.01% 5319

Other funds holding MDVL

Barclays's MDVL Position: Q2 2022 in Review

Barclays sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q2 2022, closing a stake of 44 shares — an estimated $2K sold.

Barclays first reported a position in MDVL in Q2 2020 and held it in 2 quarters. The position peaked at $11K in Q2 2020. 38 funds tracked by Wall St. Rank hold MDVL as of Q2 2022.

  • Barclays reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 44 MedAvail Holdings, Inc. Common Stock shares in Q2 2022, an estimated $2K.
  • Barclays first reported a position in MedAvail Holdings, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Barclays's MedAvail Holdings, Inc. Common Stock position peaked at $11K in Q2 2020.
  • 38 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.